argenx
is a Netherland-based biotechnology company that develops and commercializes immunotherapeutics for the treatment of autoimmune diseases... Read moreargenx
is a Netherland-based biotechnology company that develops and commercializes immunotherapeutics for the treatment of autoimmune diseases... Read more
News
Conference Presentation
Feb 25, 2025
Marketscreener
Argenx : argenx to Present at TD Cowen 45th Annual Healthcare Conference
Partnership
Nov 25, 2024
Manufacturing Chemist
Steritas and argenx join forces to advance steroid-sparing therapeutic development
investment
Nov 20, 2024
https://www.businesswire.com/news/home/20241121364834/en/OncoVerity-Secures-Extended-Series-A-to-Advance-Cusatuzumab-in-Newly-Diagnosed-AML/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT
argenx SE has invested $0 in OncoVerity, Inc.
argenx Competitors
1
2
3
4
5
6
7
8
9
10